In a study from Korea, adults with type 2 diabetes had a lower risk for autoimmune rheumatic diseases after starting an SGLT2 ...
DURAVYU now in Phase 3 for the two largest, multi-billion-dollar retinal disease markets, wet AMD and DME with first patient dosing in pivotal Phase 3 DME trials anticipated in Q1 2026 – – New ...
Diabetes mellitus, encompassing both Type 1 (T1D) and Type 2 diabetes (T2D), threatens human health on a global scale. Diabetes affects individuals of all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback